- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 102.88M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 103.26M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 87.98M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $2.23M |
| Capex | Q1 2026 · Mar 31, 2025 | $3.07M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$128.51M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$103.88M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $100.19M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $288.29M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $294.94M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $527.91M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.16B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.24B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $1.13B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $733.55M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $74.57M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $96.94M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $316.36M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $242.82M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.27B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.27B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.48B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.48B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.91 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.23 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.91 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1.23 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $34.43M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $27.94M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $104.52M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $98.82M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$94.32M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$108.33M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$107.22M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$119.29M |
| Revenue | Q1 2026 · Mar 31, 2026 | $31.74M |
| Revenue | Q1 2026 · Mar 31, 2025 | $7.47M |